Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.
about
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Pharmacokinetics and safety re ...... sk of invasive fungal disease.
@en
type
label
Pharmacokinetics and safety re ...... sk of invasive fungal disease.
@en
prefLabel
Pharmacokinetics and safety re ...... sk of invasive fungal disease.
@en
P2093
P2860
P356
P1476
Pharmacokinetics and safety re ...... isk of invasive fungal disease
@en
P2093
Andrew Grigg
Andrew J Ullmann
Deborah A Hepler
Helmut Ostermann
Hetty Waskin
Issam Raad
Johan Maertens
Kathleen M Mullane
M L P S Van Iersel
Michael N Robertson
P2860
P304
P356
10.1093/JAC/DKX263
P407
P577
2017-12-01T00:00:00Z